These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25266712)

  • 1. Acute generalized exanthematous pustulosis (AGEP) secondary to imatinib in a patient with chronic myeloid leukaemia.
    Scott AD; Lee M; Kubba F; Chu A
    Clin Exp Dermatol; 2015 Dec; 40(8):926-7. PubMed ID: 25266712
    [No Abstract]   [Full Text] [Related]  

  • 2. Imatinib-induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukemia.
    Schwarz M; Kreuzer KA; Baskaynak G; Dörken B; le Coutre P
    Eur J Haematol; 2002 Oct; 69(4):254-6. PubMed ID: 12431246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukemia.
    Brouard MC; Prins C; Mach-Pascual S; Saurat JH
    Dermatology; 2001; 203(1):57-9. PubMed ID: 11549802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib-induced pseudoporphyria.
    Martinez-Mera C; Capusan TM; Herrero-Moyano M; Urquía Renke A; Steegmann Olmedillas JL; de Argila D
    Clin Exp Dermatol; 2018 Jun; 43(4):463-466. PubMed ID: 29315788
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute generalized exanthematous pustulosis. Study of 22 cases].
    Mebazaa A; Kort R; Zaiem A; Elleuch D; Moula H; Cheikhrouhou R; Trojjet S; Mokni M; Ben Osman A; Daghfous R
    Tunis Med; 2010 Dec; 88(12):910-5. PubMed ID: 21136359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A severe case of acute generalized exanthematous pustulosis (AGEP) in a child after the administration of amoxicillin-clavulanic acid: brief report.
    Riten K; Shahina Q; Jeannette J; Palma-Diaz MF
    Pediatr Dermatol; 2009; 26(5):623-5. PubMed ID: 19840330
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
    Lee HY; Chou D; Pang SM; Thirumoorthy T
    Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin induced acute generallised exanthematous pustulosis.
    Foti C; Romita P; Zanframundo G; Mastrolonardo M; Angelini G; Calogiuri G; Nettis E; Bonamonte D
    Indian J Pharmacol; 2017; 49(1):119-120. PubMed ID: 28458435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib-induced psoriasiform eruption in a patient with chronic myeloid leukemia.
    Shi CR; Nambudiri VE
    Am J Hematol; 2018 Mar; 93(3):467-468. PubMed ID: 28836284
    [No Abstract]   [Full Text] [Related]  

  • 10. Two cases of amoxycillin-induced follicular acute localised exanthematous pustulosis.
    Rajgopal Bala H; Jalilian C; Goh MS; Williams R; Tan G; Chong AH
    Australas J Dermatol; 2017 Feb; 58(1):e23-e25. PubMed ID: 26552363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A patient of chronic myelogenous leukemia developing painful rash on feet.
    Kumar P; Das NK; Sil A; Chakrabarti P
    J Postgrad Med; 2012; 58(4):331-4. PubMed ID: 23298941
    [No Abstract]   [Full Text] [Related]  

  • 12. Heliotrope-like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia.
    Kuwano Y; Asahina A; Watanabe R; Fujimoto M; Ihn H; Tamaki K
    Int J Dermatol; 2006 Oct; 45(10):1249-51. PubMed ID: 17040457
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute generalized exanthematous pustulosis or toxic epidermal necrolysis?
    Suárez-Amor O; Cabanillas M; Monteagudo B; Ramírez-Santos A; Pérez-Valcárcel J; De Las Heras C
    Pediatr Dermatol; 2010; 27(5):559-60. PubMed ID: 21182651
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia: A six-year follow up.
    Dervis E; Ayer M; Akin Belli A; Barut SG
    Eur J Dermatol; 2016 Apr; 26(2):133-7. PubMed ID: 26679005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib mesylate-induced pseudoporphyria in a patient with chronic myeloid leukemia.
    Batrani M; Salhotra M; Kubba A; Agrawal M
    Indian J Dermatol Venereol Leprol; 2016; 82(6):727-729. PubMed ID: 27716725
    [No Abstract]   [Full Text] [Related]  

  • 16. Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia.
    Deguchi N; Kawamura T; Shimizu A; Kitamura R; Yanagi M; Shibagaki N; Matsue H; Shimada S
    Br J Dermatol; 2006 Jun; 154(6):1216-8. PubMed ID: 16704666
    [No Abstract]   [Full Text] [Related]  

  • 17. Imatinib mesylate induced erythroderma.
    Sanghavi SA; Dongre AM; Khopkar US
    Indian J Dermatol Venereol Leprol; 2012; 78(3):408. PubMed ID: 22565463
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute generalized exanthematous pustulosis induced by docetaxel.
    Ji YZ; Geng L; Qu HM; Zhou HB; Xiao T; Chen HD; Wei HC
    Int J Dermatol; 2011 Jun; 50(6):763-5. PubMed ID: 21595682
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity.
    Musolino C; Allegra A; Mannucci C; Russo S; Alonci A; Maisano V; Calapai G; Gangemi S
    Turk J Haematol; 2015 Jun; 32(2):168-71. PubMed ID: 26316486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newly diagnosed breast cancer in a patient receiving imatinib mesylate.
    Kaygusuz-Atagunduz I; Toptas T; Yumuk F; Firatli-Tuglular T; Bayik M
    J Cancer Res Ther; 2014; 10(4):1107-8. PubMed ID: 25579564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.